Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Xcenda
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Xcenda
-
Xcenda President, Kristine Flemister, speaks with
@FiercePharma about the importance of technology in expanding market and patient access. http://ow.ly/gmkU50ydk9j#marketaccess#patientaccesspic.twitter.com/cQMnqg2dgb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CMS released its Medicaid block grant proposal, “Healthy Adult Opportunity.” Learn more in the latest edition of Health Policy Weekly: http://ow.ly/JA5A50ycfvC pic.twitter.com/pijC5gQfY6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The digital revolution has transformed the
#healthcare industry by fundamentally reshaping how pharmaceutical manufacturers operate in portfolio planning, drug development,#reimbursement, brand building and other vitally important areas. http://ow.ly/xyzN50y98F2#innovationpic.twitter.com/8yJ7utm9BI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking for
#payer input to refine your clinical,#marketaccess, and/or#HEOR plans? If so, Xcenda is hosting a one-day event in Houston, Texas on April 21, 2020. Learn more about the Managed Care Network (MCN) Forum. http://ow.ly/atzc50y7sBK pic.twitter.com/PuvJbHeqjv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
There's still time to register for today's live webinar at 2:00 PM ET on the recent release of AMCP Format v4.1. Register today: http://ow.ly/7zJq50y6WO7
#amcp#amcpformatpic.twitter.com/MB4JE856kX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Supreme Court denied to fast track consideration of ACA constitutionality. Learn more in the latest edition of Health Policy Weekly: http://ow.ly/MWYX50y67Zq
#healthpolicy#acapic.twitter.com/KRNa91LFeg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With the recent release of AMCP Format v4.1, what does it mean for the preapproval information exchange between payers and manufacturers? Join us at an
@amcporg live webinar that will give guidance on the early, effective exchange of information. http://ow.ly/SCx950xXj9a pic.twitter.com/D2rzZqHduU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Democratic-led states asked the US Supreme Court to take up the case challenging the ACA’s legality. Learn more in the latest edition of Health Policy Weekly: http://ow.ly/6HNi50y1pxz
#aca#healthpolicypic.twitter.com/0npU4i9jRR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With the recent release of AMCP Format v4.1, what does it mean for the preapproval information exchange between payers and manufacturers? Join us at an
@amcporg live webinar that will give guidance on the early, effective exchange of information. http://ow.ly/SCx950xXj9a pic.twitter.com/a7dQVax9q9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In 2019, the Maryland General Assembly passed a bill to create a Prescription Drug Affordability Board (HB 768). Learn more in the latest edition of Health Policy Weekly: http://ow.ly/ku4B50xWpfO
#maryland#prescription#drugpricing#drugaffordability#hb768pic.twitter.com/MkG7wieMWQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Xcenda and the FormularyDecisions team closely tracked the development recently released AMCP Format Version 4.1 and are available to address questions and provide additional guidance surrounding these updates. Learn more: http://ow.ly/CFIz50xUs2w
#amcp#amcpformat#formularypic.twitter.com/Bn6DUiFaZw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Play an integral role in patient access to important physician-administered therapies. We are looking for Field Reimbursement Managers in several key cities across the US. Learn more: http://ow.ly/jCLJ50xQwQE
#fieldcareers#reimbursementsupport#careeropportunitiespic.twitter.com/hAs2Nyc6gM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Since 2016, 4 joint assessment agencies have been created across Europe: BeNeLuxAIr, La Valetta, Visegrad, and most recently, FINOSE (Finland, Norway, and Sweden). We take a closer look at FINOSE: http://ow.ly/qYTc50xILwc
#HTA#FINOSEpic.twitter.com/vDihTglhZF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Trump Administration announces plan to allow importation. Learn more in the latest edition of Health Policy Weekly: http://ow.ly/RlSa50xHxbl
#healthpolicy#drugimportation#hhspic.twitter.com/oQvgN1LDcM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our article in HTA Quarterly examines the current HTA landscape for advanced therapy medicinal products, such as cell and gene therapies, and the emerging HTA appraisal frameworks.
#cellandgene#CGT#marketaccess Read more: http://ow.ly/oUbz50xEttj pic.twitter.com/VGdZpKjx3Z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With million-dollar cures coming to market, what are the current perceptions of value and the role of cost-effectiveness? We explore how and when cost-effectiveness assessments are utilized for making reimbursement and pricing decisions. Read more: http://ow.ly/7n3L50xCsV7 pic.twitter.com/1jH45d6n8n
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Elijah E. Cummings Lower Drug Costs Now Act (HR 3) passed on a largely party-line vote of 230-192. Learn more in the latest edition of Health Policy Weekly: http://ow.ly/gPv850xBxYu
#healthpolicy#drugpricingpic.twitter.com/2tQP49CMvO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Xcenda proslijedio/la je Tweet
The FormularyDecisions platform from
@Xcenda was recognized as one of 2019’s most innovative services helping to push healthcare forward. Read more from@PM360online.https://bit.ly/2PGgHQRHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We were honored to present at
@www_healthecon's 1st Annual HE Innovation Webinar Series. Two of Xcenda's innovations, MetaMap Pro and Virtual Tumor Cases, were featured in a presentation that was named "Audience Favorite." Learn more: http://ow.ly/iJWu50xyXIi#HEOR#RWEpic.twitter.com/1oDZQ2Amm8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The doctor-patient relationship sits at the center of the healthcare system, but when payers insert themselves into the clinical decision-making process, it can diminish the trust and confidence patients have in their providers. Download our recent paper: http://ow.ly/JtOl50xxQGE pic.twitter.com/FQAZ12PnbU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.